Edward van der Horst

Insider Reports History

Location
Boston, MA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward van der Horst:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 59,794 $28,462 $0.4760 19 Feb 2025 Direct
Sensei Biotherapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 110,000 14 Feb 2025 Direct

Insider Reports Filed by Edward van der Horst

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 19 Feb 2025 1 -$1,083 4 CHIEF SCIENTIFIC OFFICER 26 Feb 2025, 18:44
SNSE Sensei Biotherapeutics, Inc. 14 Feb 2025 1 $0 4 CHIEF SCIENTIFIC OFFICER 14 Feb 2025, 18:01
SNSE Sensei Biotherapeutics, Inc. 20 Dec 2024 1 $0 4 CHIEF SCIENTIFIC OFFICER 23 Dec 2024, 16:15
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2024 3 -$2,246 4 CHIEF SCIENTIFIC OFFICER 16 Feb 2024, 18:37
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 1 -$14,288 4 Chief Scientific Officer 11 Sep 2023, 17:33
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 3 $0 4 Chief Scientific Officer 17 Feb 2023, 16:01
SNSE Sensei Biotherapeutics, Inc. 07 Dec 2022 0 $0 3 Chief Scientific Officer 16 Dec 2022, 15:30